2008
DOI: 10.3892/or.19.2.483
|View full text |Cite
|
Sign up to set email alerts
|

Tissue inhibitor of metalloproteinase 2 (TIMP-2) expression in adenocarcinoma pleural effusions

Abstract: Abstract. Serous effusions are frequently a clinical manifestation of metastatic disease, with lung, breast and ovarian carcinoma and mesothelioma leading the list. The diagnosis of malignant effusion signifies disease progression and is associated with a worsening patient prognosis. The ability to grow in a dense exudative fluid suggests that the malignant cells are capable of acquiring nutrients, surviving and proliferating, despite the lack of a solid-phase scaffold. During proliferation, neoplastic cells r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…Tissue inhibitors of metalloproteinases (TIMPs) are low-molecular-weight proteins that can specifically inhibit activities of MMPs [19]. Four TIMPs (TIMP-1, TIMP-2, TIMP-3 and TIMP-4) have been characterized [20].…”
Section: Introductionmentioning
confidence: 99%
“…Tissue inhibitors of metalloproteinases (TIMPs) are low-molecular-weight proteins that can specifically inhibit activities of MMPs [19]. Four TIMPs (TIMP-1, TIMP-2, TIMP-3 and TIMP-4) have been characterized [20].…”
Section: Introductionmentioning
confidence: 99%
“…TIMP-2 is considered as an interesting marker in malignant pleural effusions due to a primary tumour elsewhere in the body [6]. VEGF is another important mediator in exudative pleural effusions [7].…”
Section: Introductionmentioning
confidence: 99%